The Food and Drug Administration’s Center for Devices and Radiological Health plans to start accepting pre-submission requests for in vitro diagnostics starting on June 1, including for tests not related to COVID-19.

A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result.

This is the 68th edition of our annual ranking of America’s largest companies, and it was a blowout year for the companies featured—despite rising inflation, the ongoing supply chain crisis, and the second year of the COVID-19 pandemic.

Cardiff site will manufacture single-use bioprocessing technologies used to make vaccines and biopharmaceuticals for global customers.

Chinese precision oncology firm Burning Rock Biotech reported on Tuesday that its first quarter 2022 revenues were up 27 percent year over year.

On May 26, 2022, the team of Xiamen University, Hong Kong University, Wantai Biopharm and China National Institute for Food and Drug Control published online research results.

Quidel (Nasdaq:QDEL) announced today that it completed its $6 billion acquisition of Ortho Clinical Diagnostics (Nasdaq:OCDX).

Monkeypox is a zoonotic disease that was first identified in monkeys in 1958. Although it is named monkeypox virus, its primary host is rodents such as mice and squirrels, and its opportunistic host is primates, humans.

DoMore Diagnostics has obtained the CE mark for its Histotype Px Colorectal deep-learning algorithm to predict colorectal cancer patient outcomes based on the analysis of digital histology images, enabling its clinical use in the European Union and other geographies that accept the designation.

The World Health Organization has received reports of 257 confirmed monkeypox cases and about 120 suspected cases in 23 nations where the virus is not endemic as of Thursday, it said in a Sunday update.

In the face of the sudden monkeypox virus epidemic, many Chinese in vitro diagnostic enterprises responded quickly, completed the R & D and launched the monkeypox virus nucleic acid detection kit at the first time, effectively helping overseas to carry out the monkeypox virus prevention.

Biotech firms experienced a banner year in 2020.The COVID-19 pandemic highlighted the value of innovative medical solutions, leading to new opportunities for researchproduct approvaland funding

Becton Dickinson announced on Thursday that it has obtained the CE-IVD mark for a combined influenza, SARS-CoV-2 assay. The multiplexed RT-PCR test runs on the firm's high-throughput BD Cor system.

Roche on Wednesday said the company and its unit have developed three test kits to detect the monkeypox virus, as the disease spreads in regions outside Africa.

On May 23, 2022, Autobio Diagnostics Co., Ltd. announces CE mark for AutoMeloc Monkeypox nucleic acid detection kit (PCR-fluorescent probe method).